Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
UTI · 10-Q filed May 7, 2026

UTI earnings analysis

What we found in UTI's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Universal Technical Institute reported Q2 FY2026 results with revenues of $221.4 million, up 6.7% year-over-year, slightly exceeding estimates. However, diluted EPS of $0.01 fell short of the $0.04 estimate, attributed largely to strategic growth expenses. Management highlighted a focus on increasing student enrollments and opening new campuses as part of their diversified growth strategy.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue Growth Above Estimates
Q2 FY2026 revenue reached $221.4 million, beating estimates of $221.2 million.
EPS Misses Expectations
Diluted EPS was $0.01, missing the estimate of $0.04.
Active Student Enrollment Growth
Average full-time active students increased by 7.2% to 26,385 compared to the previous year.
Strategic Growth Initiatives
Investment of approximately $11 million in strategic growth for upcoming programs and campuses.
Segment Revenue Increases
UTI segment revenue rose by 6.3% and Concorde by 7.5%.
Operating Cash Flow
Net cash provided by operating activities was $7.1 million for the six-months ended.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Net Income Decline
Net income dropped to $433,000 from $11.4 million year-over-year.
Increased Strategic Expenses
Operating expenses surged to $426.2 million, up 16.9% due to growth initiatives.
Higher Student-Related Costs
Increased student related expenses contributed to the overall rise in operational spending.
The numbers

What they reported.

What the company itself reported, taken out of the document.

Earnings per share
$0.01
Segment
UTI: $142.7M (6.3% growth)
Segment
Concorde: $78.7M (7.5% growth)
Guidance

What they said about what is next.

Full-year guidance is reaffirmed with a focus on growth and program expansion.

How we read the filing overall

The filing reads about the same as the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · February 8, 2024
Universal Technical Institute reported strong year-over-year revenue and profitability improvement for the quarter ended December 31, 2023: revenue rose to $174.7M (from $120.0M) and operating income expanded to $14.2M…
10-Q · May 9, 2023
Universal Technical Institute reported strong revenue growth in the quarter: revenue of $163,820,000 (3 months ended March 31, 2023) up $61,734,000 (≈60.5%) year-over-year and up $43,816,000 (≈36.5%) versus the prior…
10-Q · February 9, 2023
Universal Technical Institute reported quarterly revenue of $120,004,000 (up $14,929,000 or ~14.2% vs. $105,075,000 a year ago) driven by its December 1, 2022 Concorde acquisition and other growth, but operating profit…
10-K · December 12, 2022
Universal Technical Institute (UTI) emphasizes growth through acquisitions, campus openings and program diversification while leveraging industry OEM relationships and manufacturer-specific training. The 10-K highlights…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing UTI makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever